Canada Pension Plan Investment Board grew its holdings in Medtronic PLC (NYSE:MDT) by 18.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 2,672,805 shares of the medical technology company’s stock after acquiring an additional 423,300 shares during the quarter. Canada Pension Plan Investment Board owned about 0.20% of Medtronic worth $207,864,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in MDT. Advantus Capital Management Inc boosted its position in shares of Medtronic by 0.4% in the 1st quarter. Advantus Capital Management Inc now owns 137,521 shares of the medical technology company’s stock valued at $11,079,000 after purchasing an additional 497 shares during the period. Homrich & Berg boosted its position in shares of Medtronic by 19.0% in the 1st quarter. Homrich & Berg now owns 4,991 shares of the medical technology company’s stock valued at $402,000 after purchasing an additional 798 shares during the period. Westside Investment Management Inc. boosted its position in shares of Medtronic by 114.5% in the 1st quarter. Westside Investment Management Inc. now owns 13,476 shares of the medical technology company’s stock valued at $1,081,000 after purchasing an additional 7,193 shares during the period. Israel Discount Bank of New York acquired a new stake in shares of Medtronic in the 1st quarter valued at about $117,000. Finally, Sentry Investments Corp. boosted its position in shares of Medtronic by 0.5% in the 1st quarter. Sentry Investments Corp. now owns 1,093,500 shares of the medical technology company’s stock valued at $88,092,000 after purchasing an additional 5,100 shares during the period. Institutional investors and hedge funds own 81.86% of the company’s stock.

Medtronic PLC (MDT) traded up $0.50 on Monday, hitting $81.07. The stock had a trading volume of 4,106,400 shares, compared to its average volume of 4,958,920. The company has a quick ratio of 2.05, a current ratio of 2.40 and a debt-to-equity ratio of 0.50. The firm has a market cap of $109,728.08, a PE ratio of 17.47, a P/E/G ratio of 2.24 and a beta of 1.00. Medtronic PLC has a 1-year low of $69.35 and a 1-year high of $89.72.

Medtronic (NYSE:MDT) last posted its quarterly earnings results on Tuesday, November 21st. The medical technology company reported $1.07 EPS for the quarter, beating the consensus estimate of $0.99 by $0.08. The business had revenue of $7.05 billion during the quarter, compared to analysts’ expectations of $7.05 billion. Medtronic had a return on equity of 12.63% and a net margin of 16.93%. The company’s quarterly revenue was down 4.0% compared to the same quarter last year. During the same period last year, the firm earned $1.12 EPS. sell-side analysts expect that Medtronic PLC will post 4.77 EPS for the current fiscal year.

A number of analysts recently issued reports on the company. Jefferies Group reissued a “buy” rating and issued a $99.00 target price on shares of Medtronic in a research report on Thursday, November 23rd. Zacks Investment Research raised Medtronic from a “sell” rating to a “hold” rating in a research report on Thursday, November 23rd. Northland Securities reissued a “hold” rating and issued a $80.00 target price on shares of Medtronic in a research report on Wednesday, November 22nd. Oppenheimer reissued a “buy” rating and issued a $94.00 target price on shares of Medtronic in a research report on Wednesday, November 22nd. Finally, Stifel Nicolaus upped their target price on Medtronic from $83.00 to $85.00 and gave the company a “hold” rating in a research report on Wednesday, November 22nd. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and thirteen have given a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $88.02.

In other news, CEO Omar Ishrak sold 140,407 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $81.63, for a total value of $11,461,423.41. Following the completion of the sale, the chief executive officer now directly owns 668,503 shares of the company’s stock, valued at approximately $54,569,899.89. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Bryan C. Hanson sold 16,000 shares of the firm’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $78.03, for a total value of $1,248,480.00. The disclosure for this sale can be found here. Insiders sold a total of 172,407 shares of company stock valued at $13,974,223 over the last three months. Insiders own 0.31% of the company’s stock.

WARNING: This article was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/12/11/canada-pension-plan-investment-board-buys-423300-shares-of-medtronic-plc-mdt.html.

Medtronic Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Stock Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related stocks with our FREE daily email newsletter.